Convergent Dental Inc., a privately held dental device and technology company, announced that it was unveiling Version 2 of Solea, the first FDA approved, CO2 9.3 micron dental laser for hard and soft tissue, at the Greater New York Dental Meeting (GNYDM) in New York City.
This new version of Solea offers significant improvements in cutting speed, precision and patient experience while making the unit itself even quieter, more ergonomic and easier to move around the operatory.
Solea Version 2 offers a completely redesigned handpiece, the ability to use office air as well as the internal compressor, an adjustable aiming beam, software upgrades, new wheels and more. Convergent Dental will be demonstrating the new version of this groundbreaking dental laser at Booth #4831 during the GNYDM.
Solea is a critical tool in increasing dentists’ efficiency because it enables anesthesia-free and blood-free procedures. With traditional tools, a lot of time is spent injecting patients and waiting for numbness. Using anesthesia also limits dentists to working in only one quadrant of the mouth in a visit due to the risk of the patient biting themselves and causing injury.
Rather than starting with an injection and then waiting for anesthesia to set in, Solea practitioners start right away and routinely execute multi-quadrant dentistry, fill cavities when they are discovered and perform soft tissue procedures they would never have done without a laser. This dramatically increases the value of each appointment. Solea dentists routinely perform six or more procedures per day than they did with the drill and that 95 percent of their hard and soft tissue procedures are done with no anesthesia and no bleeding.
Solea’s unique wavelength and innovative application of computer controls enable the laser to largely replace the drill and scalpel as the primary tools for hard and soft tissue surgeries. Solea earned the Medical Design Excellence Gold Award because its innovative application of technology, impact on oral health, and creative design. Solea’s features and enhancements include:
“This version of Solea demonstrates the company’s singular focus on improving dentists’ efficiency through continual innovation,” said Convergent Dental CEO Michael Cataldo. “By making it easier to perform anesthesia-free, blood-free procedures, Solea creates a significant advantage for dentists looking to increase their efficiency and grow their practice. Best of all nearly every new feature will be made available as an upgrade to existing Solea Version 1 users.”